Langerin functions as an antiviral receptor on Langerhans cells

Immunology and Cell Biology

Volumn 88, Issue 4, 2010, Pages 410-415

  Van Der Vlist, Michiel ^a   Geijtenbeek, Teunis B H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antiviral; C type lectin; HIV 1 transmission; Langerhans cell; Langerin; Pattern recognition receptor

Indexed keywords

LANGERIN; LECTIN; PATTERN RECOGNITION RECEPTOR; VIRUS ANTIBODY;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIVIRAL ACTIVITY; BIRBECK GRANULE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL ORGANELLE; CELLULAR IMMUNITY; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOMODULATION; INFECTION; INTERNALIZATION; LANGERHANS CELL; MUCOSAL IMMUNITY; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIGENS, CD; ANTIVIRAL AGENTS; HIV-1; HUMANS; LANGERHANS CELLS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; RECEPTORS, HIV; RECEPTORS, VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77952239985     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.32     Document Type: Review

References (72)

1. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449: 419-426.
2. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001; 106: 255-258.
3. Steinman RM. Dendritic cells: understanding immunogenicity. Eur J Immunol 2007; 37(Suppl 1): S53-S60.
4. Toebak MJ, Gibbs S, Bruynzeel DP, Scheper RJ, Rustemeyer T. Dendritic cells: biology of the skin. Contact Dermatitis 2009; 60: 2-20.
5. Birbeck MS. Electron microscopy of melanocytes. Br Med Bull 1962; 18: 220-222.
6. Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 2009; 206: 2937-2946.
7. van der Aar AM, Sylva-Steenland RM, Bos JD, Kapsenberg ML, de Jong EC, Teunissen MB. Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition. J Immunol 2007; 178: 1986-1990.
8. Flacher V, Bouschbacher M, Verronese E, Massacrier C, Sisirak V, Berthier-Vergnes O et al. Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J Immunol 2006; 177: 7959-7967.
9. de Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MA, de Gruijl T et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007; 13: 367-371.
10. Valladeau J, Duvert-Frances V, Pin JJ, Dezutter-Dambuyant C, Vincent C, Massacrier C et al. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol 1999; 29: 2695-2704.
11. Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y et al. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 2000; 12: 71-81.
12. Stambach NS, Taylor ME. Characterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cells. Glycobiology 2003; 13: 401-410.
13. Hunger RE, Sieling PA, Ochoa MT, Sugaya M, Burdick AE, Rea TH et al. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells Dual specificity of Langerin to sulfated and mannosylated glycans via a single C-type carbohydrate recognition domain. J Clin Invest 2004; 113: 701-708.
14. de Jong MA, Vriend LE, Theelen B, Taylor ME, Fluitsma D, Boekhout T et al. C-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi. Mol Immunol 2010; 47: 1216-1225.
15. Tateno H, Ohnishi K, Yabe R, Hayatsu N, Sato T, Takeya M et al. Dual specificity of Langerin to sulfated and mannosylated glycans via a single C-type carbohydrate recognition domain. J Biol Chem 2010; 285: 6390-6400.
16. Mc Dermott R, Ziylan U, Spehner D, Bausinger H, Lipsker D, Mommaas M et al. Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates. Mol Biol Cell 2002; 13: 317-335.
17. Idoyaga J, Cheong C, Suda K, Suda N, Kim JY, Lee H et al. Cutting edge: langerin/ CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J Immunol 2008; 180: 3647-3650.
18. de Jong MA, de Witte L, Oudhoff MJ, Gringhuis SI, Gallay P, Geijtenbeek TB. TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J Clin Invest 2008; 118: 3440-3452.
19. Ogawa Y, Kawamura T, Kimura T, Ito M, Blauvelt A, Shimada S. Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation. Blood 2009; 113: 5157-5166.
20. Shortman K, Lahoud MH, Caminschi I. Improving vaccines by targeting antigens to dendritic cells. Exp Mol Med 2009; 41: 61-66.
21. Geijtenbeek TB, Gringhuis SI. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 2009; 9: 465-479.
22. Sancho D, Joffre OP, Keller AM, Rogers NC, Martínez D, Hernanz-Falcón P et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009; 458: 899-903.
23. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100: 587-597.
24. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100: 575-585.
25. Burleigh L, Lozach PY, Schiffer C, Staropoli I, Pezo V, Porrot F et al. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells. J Virol 2006; 80: 2949-2957.
26. Turville SG, Santos JJ, Frank I, Cameron PU, Wilkinson J, Miranda-Saksena M et al. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 2004; 103: 2170-2179.
27. de Witte L, de Vries RD, van der Vlist M, Yü ksel S, Litjens M, de Swart RL et al. DCSIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes. PLoS Pathog 2008; 4: e1000049.
28. Jain P, Manuel SL, Khan ZK, Ahuja J, Quann K, Wigdahl B. DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells. J Virol 2009; 83: 10908-10921.
29. Geijtenbeek TB, van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke- Grauls CM, Appelmelk B et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 2003; 197: 7-17.
30. Bergman MP, Engering A, Smits HH, van Vliet SJ, van Bodegraven AA, Wirth HP et al. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J ExpMed 2004; 200: 979-990.
31. Kamada N, Hisamatsu T, Honda H, Kobayashi T, Chinen H, Kitazume MT et al. Human CD14+ macrophages in intestinal lamina propria exhibit potent antigen-presenting ability. J Immunol 2009; 183: 1724-1731.
32. Poulin LF, Henri S, de BB, Devilard E, Kissenpfennig A, Malissen B. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 2007; 204: 3119-3131.
33. Bursch LS, Wang L, Igyarto B, Kissenpfennig A, Malissen B, Kaplan DH et al. Identification of a novel population of Langerin+ dendritic cells. J Exp Med 2007; 204: 3147-3156.
34. Ginhoux F, Collin MP, Bogunovic M, Abel M, Leboeuf M, Helft J et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J Exp Med 2007; 204: 3133-3146.
35. Maeda N, Nigou J, Herrmann JL, Jackson M, Amara A, Lagrange PH et al. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J Biol Chem 2003; 278: 5513-5516.
36. Engering A, Geijtenbeek TB, van Vliet SJ, Wijers M, van Liempt E, Demaurex N et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 2002; 168: 2118-2126.
37. Weis WI, Taylor ME, Drickamer K. The C-type lectin superfamily in the immune system. Immunol Rev 1998; 163: 19-34.
38. Chatwell L, Holla A, Kaufer BB, Skerra A. The carbohydrate recognition domain of Langerin reveals high structural similarity with the one of DC-SIGN but an additional, calcium-independent sugar-binding site. Mol Immunol 2008; 45: 1981-1994.
39. Thepaut M, Valladeau J, Nurisso A, Kahn R, Arnou B, Vivès C et al. Structural studies of langerin and Birbeck granule: a macromolecular organization model. Biochemistry 2009; 48: 2684-2698.
40. Bowdish DM, Gordon S. Conserved domains of the class A scavenger receptors: evolution and function. Immunol Rev 2009; 227: 19-31.
41. de Jong MA, de Witte L, Geijtenbeek TB. Isolation of immature primary Langerhans cells from human epidermal skin. Methods Mol Biol 2010; 595: 55-65.
42. Takahara K, Omatsu Y, Yashima Y, Maeda Y, Tanaka S, Iyoda T et al. Identification and expression of mouse Langerin (CD207) in dendritic cells. Int Immunol 2002; 14: 433-444.
43. Turville SG, Arthos J, Donald KM, Lynch G, Naif H, Clark G et al. HIV gp120 receptors on human dendritic cells. Blood 2001; 98: 2482-2488.
44. Karkowska-Kuleta J, Rapala-Kozik M, Kozik A. Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Acta Biochim Pol 2009; 56: 211-224.
45. Verdijk P, Dijkman R, Plasmeijer EI, Mulder AA, Zoutman WH, Mieke Mommaas A et al. A lack of Birbeck granules in Langerhans cells is associated with a naturally occurring point mutation in the human Langerin gene. J Invest Dermatol 2005; 124: 714-717.
46. Li SS. Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem J 2005; 390: 641-653.
47. Uzan-Gafsou S, Bausinger H, Proamer F, Monier S, Lipsker D, Cazenave JP et al. Rab11A controls the biogenesis of Birbeck granules by regulating Langerin recycling and stability. Mol Biol Cell 2007; 18: 3169-3179.
48. De Libero G, Mori L. How T cells get grip on lipid antigens. Curr Opin Immunol 2008; 20: 96-104.
49. Sugita M, Grant EP, van DE, Hsu VW, Rogers RA, Peters PJ et al. Separate pathways for antigen presentation by CD1molecules. Immunity 1999; 11: 743-752.
50. Rocha N, Neefjes J. MHC class II molecules on the move for successful antigen presentation. EMBO J 2008; 27: 1-5.
51. Flacher V, Tripp CH, Stoitzner P, Haid B, Ebner S, Del Frari B et al. Epidermal langerhans cells rapidly capture and present antigens from C-Type lectin-targeting antibodies deposited in the dermis. J Invest Dermatol 2010; 130: 755-762 e-pub 5 Nov 2009.
52. Turville SG, Cameron PU, Handley A, Lin G, Pöhlmann S, Doms RW et al. Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol 2002; 3: 975-983.
53. Geyer H, Holschbach C, Hunsmann G, Schneider J. Carbohydrates of human immunodeficiency virus Structures of oligosaccharides linked to the envelope glycoprotein 120. J Biol Chem 1988; 263: 11760-11767.
54. Mizuochi T, Spellman MW, Larkin M, Solomon J, Basa LJ, Feizi T. Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells. Biochem J 1988; 254: 599-603.
55. Boy SC, van Heerden MB, Wolfaardt M, Cockeran R, Gema E, van Heerden WF. An investigation of the role of oral epithelial cells and Langerhans cells as possible HIV viral reservoirs. J Oral Pathol Med 2009; 38: 114-119.
56. Kawamura T, Cohen SS, Borris DL, Aquilino EA, Glushakova S, Margolis LB et al. Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J Exp Med 2000; 192: 1491-1500.
57. Hladik F, Sakchalathorn P, Ballweber L, Lentz G, Fialkow M, Eschenbach D et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007; 26: 257-270.
58. Sivard P, Berlier W, Picard B, Sabido O, Genin C, Misery L. HIV-1 infection of Langerhans cells in a reconstructed vaginal mucosa. J Infect Dis 2004; 190: 227-235.
59. Toossi Z. Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease. J Infect Dis 2003; 188: 1146-1155.
60. Ranjbar S, Boshoff HI, Mulder A, Siddiqi N, Rubin EJ, Goldfeld AE. HIV-1 replication is differentially regulated by distinct clinical strains of Mycobacterium tuberculosis. PLoS One 2009; 4: e6116.
61. Lawn SD. AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. J Infect 2004; 48: 1-12.
62. Kawamura T, Koyanagi Y, Nakamura Y, Ogawa Y, Yamashita A, Iwamoto T et al. Significant virus replication in Langerhans cells following application of HIV to abraded skin: relevance to occupational transmission of HIV. J Immunol 2008; 180: 3297-3304.
63. Fahrbach KM, Barry SM, Ayehunie S, Lamore S, Klausner M, Hope TJ. Activated CD34- derived Langerhans cells mediate transinfection with human immunodeficiency virus. J Virol 2007; 81: 6858-6868.
64. Kunanusont C, Foy HM, Kreiss JK, Rerks-Ngarm S, Phanuphak P, Raktham S et al. HIV-1 subtypes and male-to-female transmission in Thailand. Lancet 1995; 345: 1078-1083.
65. Bhoopat L, Eiangleng L, Rugpao S, Frankel SS, Weissman D, Lekawanvijit S et al. In vivo identification of Langerhans and related dendritic cells infected with HIV-1 subtype E in vaginal mucosa of asymptomatic patients. Mod Pathol 2001; 14: 1263-1269.
66. Soto-Ramirez LE, Renjifo B, McLane MF, Marlink R, O'Hara C, Sutthent R et al. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996; 271: 1291-1293.
67. Gringhuis SI, den Dunnen J, Litjens M, van het Hof B, van Kooyk Y, Geijtenbeek TB. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 2007; 26: 605-616.
68. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TB. Carbohydratespecific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat Immunol 2009; 10: 1081-1088.
69. Smith AL, Ganesh L, Leung K, Jongstra-Bilen J, Jongstra J, Nabel GJ. Leukocytespecific protein 1 interacts with DC-SIGN and mediates transport of HIV to the proteasome in dendritic cells. J Exp Med 2007; 204: 421-430.
70. Ward EM, Stambach NS, Drickamer K, Taylor ME. Polymorphisms in human langerin affect stability and sugar binding activity. J Biol Chem 2006; 281: 15450-15456.
71. Ortiz M, Kaessmann H, Zhang K, Bashirova A, Carrington M, Quintana-Murci L et al. The evolutionary history of the CD209 (DC-SIGN) family in humans and non-human primates. Genes Immun 2008; 9: 483-492.
72. Barreiro LB, Patin E, Neyrolles O, Cann HM, Gicquel B, Quintana-Murci L. The heritage of pathogen pressures and ancient demography in the human innate-immunity CD209/ CD209L region. Am J Hum Genet 2005; 77: 869-886.